{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:01:37Z","timestamp":1780542097182,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04908-7","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:13:48Z","timestamp":1780539228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of anticancer activity of beta glucan in non-alcoholic steatohepatitis associated hepatocellular carcinoma in rats"],"prefix":"10.1007","volume":"96","author":[{"given":"Sonia","family":"Bisht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeetha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"4908_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.livres.2023.11.004","volume":"7","author":"W Abdelhamed","year":"2023","unstructured":"Abdelhamed W, El-Kassas M (2023) Hepatocellular carcinoma recurrence: Predictors and management. Liver Res 7:321\u2013332. https:\/\/doi.org\/10.1016\/j.livres.2023.11.004","journal-title":"Liver Res"},{"key":"4908_CR2","doi-asserted-by":"publisher","first-page":"101447","DOI":"10.1016\/j.jceh.2024.101447","volume":"14","author":"S Giri","year":"2024","unstructured":"Giri S, Singh A (2024) Epidemiology of Hepatocellular Carcinoma in India \u2013 An Updated Review for 2024. J Clin Exp Hepatol 14:101447. https:\/\/doi.org\/10.1016\/j.jceh.2024.101447","journal-title":"J Clin Exp Hepatol"},{"key":"4908_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43066-023-00306-3","volume":"14","author":"TA Addissouky","year":"2024","unstructured":"Addissouky TA, Sayed IET, El, Ali MMA et al (2024) Latest advances in hepatocellular carcinoma management and prevention through advanced technologies. Egypt Liver J 14:2. https:\/\/doi.org\/10.1186\/s43066-023-00306-3","journal-title":"Egypt Liver J"},{"key":"4908_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/diseases13070207","volume":"13","author":"N Amin","year":"2025","unstructured":"Amin N, Anwar J, Sulaiman A et al (2025) Hepatocellular Carcinoma: A Comprehensive Review. Diseases 13:207. https:\/\/doi.org\/10.3390\/diseases13070207","journal-title":"Diseases"},{"key":"4908_CR5","doi-asserted-by":"publisher","first-page":"100305","DOI":"10.1016\/j.jhepr.2021.100305","volume":"3","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Henry L (2021) Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP Rep 3:100305. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100305","journal-title":"JHEP Rep"},{"key":"4908_CR6","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.1001057","volume-title":"Risk Factors Associated With Development of Hepatocellular Carcinoma in Hepatitis C Virus Patients","author":"R El-Shenawy","year":"2023","unstructured":"El-Shenawy R, Farouk S, Helmy N, Bader El Din N (2023) Risk Factors Associated With Development of Hepatocellular Carcinoma in Hepatitis C Virus Patients. Hepatitis C - Recent Advances. IntechOpen, morIn"},{"key":"4908_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2147\/JHC.S347959","volume":"10","author":"T Ito","year":"2023","unstructured":"Ito T, Nguyen MH (2023) Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes. J Hepatocell Carcinoma Volume 10:413\u2013428. https:\/\/doi.org\/10.2147\/JHC.S347959","journal-title":"J Hepatocell Carcinoma Volume"},{"key":"4908_CR8","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.3390\/cancers15225458","volume":"15","author":"BM Motta","year":"2023","unstructured":"Motta BM, Masarone M, Torre P, Persico M (2023) From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention. Cancers (Basel) 15:5458. https:\/\/doi.org\/10.3390\/cancers15225458","journal-title":"Cancers (Basel)"},{"key":"4908_CR9","doi-asserted-by":"publisher","first-page":"100613","DOI":"10.1016\/j.obmed.2025.100613","volume":"55","author":"SO Oladipupo","year":"2025","unstructured":"Oladipupo SO, Ezenabor EH, Ojo AB et al (2025) Interplay of the pathophysiological mechanisms of non-alcoholic fatty liver disease, diabetes mellitus, and inflammation: A growing threat to public health. Obes Med 55:100613. https:\/\/doi.org\/10.1016\/j.obmed.2025.100613","journal-title":"Obes Med"},{"key":"4908_CR10","doi-asserted-by":"publisher","first-page":"100811","DOI":"10.1016\/j.jhepr.2023.100811","volume":"5","author":"S Talamantes","year":"2023","unstructured":"Talamantes S, Lisjak M, Gilglioni EH et al (2023) Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Rep 5:100811. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100811","journal-title":"JHEP Rep"},{"key":"4908_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S2468-1253(24)00247-4","volume":"10","author":"B-Y Zhong","year":"2025","unstructured":"Zhong B-Y, Fan W, Guan JJ et al (2025) Combination locoregional and systemic therapies in hepatocellular carcinoma. Lancet Gastroenterol Hepatol 10:369\u2013386. https:\/\/doi.org\/10.1016\/S2468-1253(24)00247-4","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4908_CR12","doi-asserted-by":"publisher","unstructured":"Ntellas P, Chau I (2024) Updates on Systemic Therapy for Hepatocellular Carcinoma. Am Soc Clin Oncol Educational Book 44. https:\/\/doi.org\/10.1200\/EDBK_430028","DOI":"10.1200\/EDBK_430028"},{"key":"4908_CR13","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.3390\/cancers16132387","volume":"16","author":"M Moriguchi","year":"2024","unstructured":"Moriguchi M, Kataoka S, Itoh Y (2024) Evolution of Systemic Treatment for Hepatocellular Carcinoma: Changing Treatment Strategies and Concepts. Cancers (Basel) 16:2387. https:\/\/doi.org\/10.3390\/cancers16132387","journal-title":"Cancers (Basel)"},{"key":"4908_CR14","doi-asserted-by":"publisher","first-page":"113248","DOI":"10.1016\/j.ejca.2023.113248","volume":"192","author":"N Ben Khaled","year":"2023","unstructured":"Ben Khaled N, M\u00f6rtl B, Beier D et al (2023) Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study. Eur J Cancer 192:113248. https:\/\/doi.org\/10.1016\/j.ejca.2023.113248","journal-title":"Eur J Cancer"},{"key":"4908_CR15","doi-asserted-by":"publisher","first-page":"100749","DOI":"10.1016\/j.focha.2024.100749","volume":"5","author":"A Vignesh","year":"2024","unstructured":"Vignesh A, Amal TC, Sarvalingam A, Vasanth K (2024) A review on the influence of nutraceuticals and functional foods on health. Food Chem Adv 5:100749. https:\/\/doi.org\/10.1016\/j.focha.2024.100749","journal-title":"Food Chem Adv"},{"key":"4908_CR16","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/nu15092124","volume":"15","author":"A Lante","year":"2023","unstructured":"Lante A, Canazza E, Tessari P (2023) Beta-Glucans of Cereals: Functional and Technological Properties. Nutrients 15:2124. https:\/\/doi.org\/10.3390\/nu15092124","journal-title":"Nutrients"},{"key":"4908_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.procbio.2024.09.011","volume":"147","author":"GI Edo","year":"2024","unstructured":"Edo GI, Ndudi W, Makia RS et al (2024) Beta-glucan: An overview in biological activities, derivatives, properties, modifications and current advancements in food, health and industrial applications. Process Biochem 147:347\u2013370. https:\/\/doi.org\/10.1016\/j.procbio.2024.09.011","journal-title":"Process Biochem"},{"key":"4908_CR18","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/pharmaceutics15061615","volume":"15","author":"X Zhong","year":"2023","unstructured":"Zhong X, Wang G, Li F et al (2023) Immunomodulatory Effect and Biological Significance of \u03b2-Glucans. Pharmaceutics 15:1615. https:\/\/doi.org\/10.3390\/pharmaceutics15061615","journal-title":"Pharmaceutics"},{"key":"4908_CR19","doi-asserted-by":"publisher","unstructured":"Noorbakhsh Varnosfaderani SM, Ebrahimzadeh F, Akbari Oryani M et al (2024) Potential promising anticancer applications of \u03b2-glucans: a review. Biosci Rep 44. https:\/\/doi.org\/10.1042\/BSR20231686","DOI":"10.1042\/BSR20231686"},{"key":"4908_CR20","doi-asserted-by":"publisher","first-page":"100394","DOI":"10.1016\/j.microb.2025.100394","volume":"7","author":"GI Edo","year":"2025","unstructured":"Edo GI, Mafe AN, Ali ABM et al (2025) A critical review on the impacts of \u03b2-glucans on gut microbiota and human health. Microbe 7:100394. https:\/\/doi.org\/10.1016\/j.microb.2025.100394","journal-title":"Microbe"},{"key":"4908_CR21","doi-asserted-by":"publisher","unstructured":"Zheng J, Shen N, Wang S, Zhao G (2013) Oat beta-glucan ameliorates insulin resistance in mice fed on high-fat and high-fructose diet. Food Nutr Res 57. https:\/\/doi.org\/10.3402\/fnr.v57i0.22754","DOI":"10.3402\/fnr.v57i0.22754"},{"key":"4908_CR22","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1158\/1078-0432.CCR-10-0820","volume":"16","author":"B Li","year":"2010","unstructured":"Li B, Cai Y, Qi C et al (2010) Orally Administered Particulate \u03b2-Glucan Modulates Tumor-Capturing Dendritic Cells and Improves Antitumor T-Cell Responses in Cancer. Clin Cancer Res 16:5153\u20135164. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0820","journal-title":"Clin Cancer Res"},{"key":"4908_CR23","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.7150\/ijms.72987","volume":"19","author":"V Kerdput","year":"2022","unstructured":"Kerdput V, Kanjanapongkul K, Itharat A et al (2022) Molecular Changes Following Induction of Hepatocellular Carcinoma by Diethylnitrosamine and Thioacetamide, and Subsequent Treatment with Dioscorea membranacea Extract. Int J Med Sci 19:1806\u20131815. https:\/\/doi.org\/10.7150\/ijms.72987","journal-title":"Int J Med Sci"},{"key":"4908_CR24","first-page":"181","volume":"13","author":"R W\u00f3jcik","year":"2010","unstructured":"W\u00f3jcik R (2010) Effect of Biolex Beta-HP on phagocytic activity and oxidative metabolism of peripheral blood granulocytes and monocytes in rats intoxicated by cyclophosphamide. Pol J Vet Sci 13:181\u2013188","journal-title":"Pol J Vet Sci"},{"key":"4908_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1475-2891-13-38","volume":"13","author":"H Stier","year":"2014","unstructured":"Stier H, Ebbeskotte V, Gruenwald J (2014) Immune-modulatory effects of dietary Yeast Beta-1,3\/1,6-D-glucan. Nutr J 13:38. https:\/\/doi.org\/10.1186\/1475-2891-13-38","journal-title":"Nutr J"},{"key":"4908_CR26","doi-asserted-by":"publisher","first-page":"117118","DOI":"10.1016\/j.biopha.2024.117118","volume":"177","author":"Q Fan","year":"2024","unstructured":"Fan Q, Tian H, Cheng J et al (2024) Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update. Biomed Pharmacother 177:117118. https:\/\/doi.org\/10.1016\/j.biopha.2024.117118","journal-title":"Biomed Pharmacother"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04908-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04908-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04908-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:13:49Z","timestamp":1780539229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04908-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4908"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04908-7","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"61"}}